Company Biography
At Merus, we are clinically advancing leading-edge, targeted treatments to address the unmet needs of patients with various types of cancer. Utilizing our proprietary technology platforms, we are developing innovative multispecific antibody therapeutics, referred to as Multiclonics®.
You have chosen to your
information with
Merus
Team Members
JJ Ferrer
Merus
Executive Director of Precision Medicine Marketing
William Jenkinson
Merus
Executive Director of Marketing